The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? - Wikidata - wikimedia - TriplyDB

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

http://www.wikidata.org/entity/Q48315717

about

Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease Biomarkers in dementia: clinical utility and new directions Introducing Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, an open access journal of the Alzheimer's Association One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.Directional information flow in patients with Alzheimer's disease. A source-space resting-state MEG study.Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.Increased CSF neurogranin concentration is specific to Alzheimer disease.Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease.The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease.A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.Angelica sinensis reduced Aβ-induced memory impairment in rats.Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.

P2860

Q26781562-6AF5A7DD-CAA4-4696-AC32-C823C196608D Q26853347-1FDA0DF4-8648-4531-B8AA-5CA7A741BC10 Q27007086-CFF6A8B3-2C04-4319-992B-DB8874BFA67B Q30489394-B2189A32-D176-466C-A37D-E65CE99D9999 Q33808324-C0654B1C-C8E7-4C49-AFB3-C77448314A81 Q33840101-CEFDCADA-C0F9-4234-A488-0488D334A3DC Q35750755-BF63B63D-5865-4069-B5A5-B4AE812B0CBB Q35857978-39ECF1E1-431F-4947-A57B-B89B870B2A7E Q36217479-DB0A96E5-F45B-4991-A9E1-15456EC30C78 Q36404504-7688EDEB-49B0-41CF-842A-48B65D9F6EDA Q36454535-D963F17A-E9DF-40D8-BAE6-F0AA6C07B0DD Q36515507-7F358628-364B-4837-8E96-A2E50A4B55F5 Q36639655-535B7031-BDAC-4AC0-BACC-3745566752AF Q36651546-B6350BBE-4745-474F-977A-5596C905344B Q36691986-3EB14790-B038-4425-B15C-778C122C52B5 Q36764582-49A5F018-2C9B-4C27-988F-835D0251B099 Q36834554-C82A3CD5-542D-497A-A58D-FBC89398074D Q36934163-67EF77E7-46C1-4D3D-A7CB-9C094A6482C2 Q37169136-5EDE1F3D-6F52-4AEE-B40E-CEEF28DD95AB Q37310159-C068FBDD-4C52-4D9B-9D8D-881169EB4033 Q37451440-ADD1EFD1-005E-45DE-8A16-8A837559129E Q37487835-87208FE1-F749-4222-B407-C8FFC0A489AB Q37648226-2349C7DF-4231-4B3B-B4EC-84A4ACF19BD2 Q37665017-F0AB0077-761D-4E26-BA0E-E0AEC1CB00F5 Q37695162-DB2F15E2-731A-408C-9E6A-582CBC6FC168 Q37703133-AE8FF292-12A9-4CCF-8699-E5992BFB23A3 Q38289739-A3BDF18F-5DB8-4EE4-8861-2E6EF34EC490 Q38661989-D921B928-5957-4A8A-9339-E91AD9B27830 Q38773523-39AAA133-EE1B-4CE3-B5E3-359FE9651B29 Q38798611-B39D9BC3-FFBE-4E8F-B47A-2B305C824CA3 Q38802883-E24C60F6-178A-4AC8-8EC0-4196AE6E6ABC Q38827967-2258E7F2-964F-41DB-B478-1A9C5417DEB1 Q38853776-06F36EF2-CCCD-4EF6-BAAD-3E69396752F4 Q38979999-44B52858-F5E8-405F-B184-6FA162A7BFF9 Q39107119-324E5737-E27B-42E1-8C7C-B2F63F2BFD9A Q39342351-07F5EF67-6F1D-4FC1-878D-C0F519F43383 Q39432592-E247E51A-395F-4240-9C42-9CF4732A5C4B Q39644582-62E34AB4-1F71-4737-BFDD-7E57E66B3517 Q40153300-6A7369BB-4055-4E18-8712-B2BF7D774B51 Q40277605-97821BDA-8F2F-43B0-8FF0-96A612CC8490

P2860

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

http://www.wikidata.org/entity/Q48315717

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@en

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@nl

type

label

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@en

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@nl

prefLabel

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@en

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@nl

P1433

Q48315717-64460FB1-F35F-4EF0-806E-0212A698D624

P1476

Q48315717-0B2359CD-6EAC-4377-A989-EE296DE634CB

P2093

Q48315717-4567DFEB-1746-4C69-951B-4A053293E3B0

Q48315717-5AA67DD7-A05B-43D6-BAAE-C15B1A3E371D

Q48315717-71A28086-B4F7-48F0-83CC-08F482F1FF5B

Q48315717-843E7FDC-E09E-4BC4-9931-2ABFC8D407B8

Q48315717-B6030A70-37EB-49FD-BD75-6883E69A53C9

Q48315717-CEE5A467-4A18-4E7C-A32F-21D48B8C489C

Q48315717-D33828D3-2EBE-42AE-A8C4-36D4729222EA

Q48315717-FCBE9FAD-AC8F-4CF2-B080-7236BF3830D5

Q48315717-FF3AB024-D3A7-4F77-971F-A047180ECFE0

P304

Q48315717-95F52BFC-B0DD-417C-AF3E-C17E9A28A513

P31

Q48315717-8CC27BCA-D8BD-4B4B-BAD1-6BE6E0FAE56C

P356

Q48315717-36BCDF22-1837-4EE8-AE76-4C312D1C708C

P433

Q48315717-C95CF757-357E-4F26-86F4-555DD8F588D0

P478

Q48315717-465855CD-BE32-4067-A70E-1EB2CDAD5BEE

P50

Q48315717-0B9ACC23-E03C-4043-8E04-92819798F039

Q48315717-1DCB7E25-F838-4028-A9A4-F5E74D05FDA9

Q48315717-1E4D5084-BAFB-4375-AD52-6B8CA19772B3

Q48315717-26CDA333-BC1E-4B28-B8E2-2DCCDCC845B7

Q48315717-38F79811-577D-4FF5-9606-66E67DF101AF

Q48315717-6C0D27EF-B1D2-4AC2-AA4D-AE5E78568DAE

Q48315717-73C8C318-DA10-40B3-BC94-F8ED3E9F62B7

Q48315717-7C5B30E2-3BA1-4645-B443-7A32E0B09DB1

Q48315717-8C095D24-AEDD-45F9-B117-952C2864C87C

Q48315717-8E47E63F-1077-4851-A628-D87627CAD70A

P577

Q48315717-603465A9-AF74-4343-A9EE-F14CB22551D9

P5875

Q48315717-4409F06E-0A31-4E37-8AB4-D6999376B98F

P698

Q48315717-0042CE23-8A8A-456E-823D-1F88759DE6EF

P921

Q48315717-1C8C6307-E573-457C-AC83-58FE83AC2288

Q48315717-4BF0EE49-C080-45BF-95A2-991F1825844F

P356

J.JALZ.2013.12.023

P1433

Alzheimer's and Dementia

P1476

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

@en

P2093

Anders Wallin

http://www.w3.org/2001/XMLSchema#string

Femke H Bouwman

http://www.w3.org/2001/XMLSchema#string

Flora H Duits

http://www.w3.org/2001/XMLSchema#string

Jan Marcusson

http://www.w3.org/2001/XMLSchema#string

Johannes Schröder

http://www.w3.org/2001/XMLSchema#string

Lucilla Parnetti

http://www.w3.org/2001/XMLSchema#string

Marcel Olde Rikkert

http://www.w3.org/2001/XMLSchema#string

Niels Andreasen

http://www.w3.org/2001/XMLSchema#string

Pieter-Jelle Visser

http://www.w3.org/2001/XMLSchema#string

P304

713-723.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2013.12.023

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Philip Scheltens

Sanna-Kaisa Herukka

Marinus A. Blankenstein

Charlotte Teunissen

Niklas Mattsson

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261602339

http://www.w3.org/2001/XMLSchema#string

P698

24721526

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid